European journal of internal medicine
-
Eur. J. Intern. Med. · Aug 2022
Atrial cardiomyopathy markers and new-onset atrial fibrillation risk in patients with acute myocardial infarction.
New-onset atrial fibrillation (NOAF) after acute myocardial infarction (AMI) is common and independently correlated with poor prognosis. The purpose of this study is to explore whether atrial cardiomyopathy (ACM) markers improve NOAF risk assessment and contribute to therapy decision-making to improve prognosis. ⋯ Atrial cardiomyopathy markers including PTFV1, LAD, and BNP were strongly associated with NOAF after AMI. The prediction performance of the clinical model for NOAF was increased by the addition of these markers.